← Leaderboards
Juhi Bagaitkar
Research Inst Nationwide Children'S Hosp
$4,276,428
Attributed
$5,979,343
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,979,343 · 4
By mechanism
R01$5,671,343 · 3
R03$308,000 · 1
Top collaborators
- Jan S Potempa4 shared
- Richard J Lamont3 shared
Most similar at Research Inst Nationwide Children'S Hosp
Same institution · by research overlap
- Richard J Lamont$30,829,505
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsNeutrophilChronicDysbiosisInflammatoryInflammationGingivaPlayTissuesPeriodontal DiseasesImmuneOralPeriodontitisComplexEnzymesResolutionAntimicrobialOral CavityGenesOral Mucous Membrane StructureInsightCytokineIn VivoInflammatory Response
Grant awards (15)
A T.fosythia-derived protease inhibitor in periodontal health and disease$539,501
R01 · FY2025 · DE
Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis$417,169
R01 · FY2025 · DE · contact PI
Redox Regulation of Gingival Inflammation$432,903
R01 · FY2024 · DE · contact PI
Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis$408,827
R01 · FY2024 · DE · contact PI
A T.fosythia-derived protease inhibitor in periodontal health and disease$533,796
R01 · FY2023 · DE
Redox Regulation of Gingival Inflammation$457,260
R01 · FY2023 · DE · contact PI
Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis$431,169
R01 · FY2023 · DE · contact PI
A T.fosythia-derived protease inhibitor in periodontal health and disease$528,458
R01 · FY2022 · DE
Redox Regulation of Gingival Inflammation$367,312
R01 · FY2022 · DE · contact PI
Redox Regulation of Gingival Inflammation$90,544
R01 · FY2022 · DE · contact PI
A T.fosythia-derived protease inhibitor in periodontal health and disease$546,911
R01 · FY2021 · DE
Redox Regulation of Gingival Inflammation$475,027
R01 · FY2021 · DE · contact PI
Redox Regulation of Gingival Inflammation$442,466
R01 · FY2020 · DE · contact PI
A novel role for NADPH oxidase in modulating neutrophil functions in periodontal disease$154,000
R03 · FY2019 · DE · contact PI
A novel role for NADPH oxidase in modulating neutrophil functions in periodontal disease$154,000
R03 · FY2018 · DE · contact PI